Evidence map›Paper›PMID 25339658›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

AID-initiated DNA lesions are differentially processed in distinct B cell populations.

Zhangguo Chen, Sheila Ranganath, Sawanee S Viboolsittiseri, Maxwell D Eder, Xiaomi Chen, Mihret T Elos, Shunzong Yuan, Shunzhong Yuan, Erica Hansen, Jing H Wang

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhangguo ChenDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045; Department of Biomedical Research, National Jewish Health, Denver, CO 80206; and jing.wang@ucdenver.edu zhangguo.chen@ucdenver.edu.
Sheila RanganathBoston Children's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Sawanee S ViboolsittiseriDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045;
Maxwell D EderDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045;
Xiaomi ChenDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045; Department of Biomedical Research, National Jewish Health, Denver, CO 80206; and.
Mihret T ElosDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045;
Shunzong YuanDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045;
Shunzhong Yuan
Erica HansenBoston Children's Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
Jing H WangDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045; Department of Biomedical Research, National Jewish Health, Denver, CO 80206; and jing.wang@ucdenver.edu zhangguo.chen@ucdenver.edu.
University of Colorado Denver · USHoward Hughes Medical Institute · USNational Jewish Health · US

Funding

Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
Mechanisms promoting translocations and mature B cell lymphomasR01CA166325 · NCI · UNIVERSITY OF COLORADO DENVER · PI WANG, JING HONG · 2012 to 2016
$1.7M
Howard Hughes Medical InstituteNCI NIH HHS 3R01CA166325-02S1NCI NIH HHS R01 CA166325NCI NIH HHS R01 CA166325-01A1NIAID NIH HHS T32 AI074491
6 · The paper itself

Abstract

Activation-induced deaminase (AID) initiates U:G mismatches, causing point mutations or DNA double-stranded breaks at Ig loci. How AID-initiated lesions are prevented from inducing genome-wide damage remains elusive. A differential DNA repair mechanism might protect certain non-Ig loci such as c-myc from AID attack. However, determinants regulating such protective mechanisms are largely unknown. To test whether target DNA sequences modulate protective mechanisms via altering the processing manner of AID-initiated lesions, we established a knock-in model by inserting an Sγ2b region, a bona fide AID target, into the first intron of c-myc. Unexpectedly, we found that the inserted S region did not mutate or enhance c-myc genomic instability, due to error-free repair of AID-initiated lesions, in Ag-stimulated germinal center B cells. In contrast, in vitro cytokine-activated B cells display a much higher level of c-myc genomic instability in an AID- and S region-dependent manner. Furthermore, we observe a comparable frequency of AID deamination events between the c-myc intronic sequence and inserted S region in different B cell populations, demonstrating a similar frequency of AID targeting. Thus, our study reveals a clear difference between germinal center and cytokine-activated B cells in their ability to develop genomic instability, attributable to a differential processing of AID-initiated lesions in distinct B cell populations. We propose that locus-specific regulatory mechanisms (e.g., transcription) appear to not only override the effects of S region sequence on AID targeting frequency but also influence the repair manner of AID-initiated lesions.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesB-Lymphocyte SubsetsCells, CulturedCytidine DeaminaseCytokinesDNA RepairGene Knock-In TechniquesGenetic LociGenomic InstabilityGerminal CenterHumansIntronsMice, 129 StrainMutationAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseCytokinesProto-Oncogene Proteins c-myc

Identifiers

PMID25339658
PMCPMC4239163
OpenAlexW1666018685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.